Cargando…
Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder
Psychosocial support is recommended in conjunction with medication for opioid use disorder (MOUD), although optimal “dose,” modality, and timing of participation is not established. This study comprised a secondary analysis of counseling and 12-Step attendance and subsequent opioid use in a MOUD ran...
Autores principales: | Hefner, Kathryn, Choo, Tse-Hwei, Shmueli-Blumberg, Dikla, Pavlicova, Martina, King, Jacquie, Fishman, Marc, Shulman, Matisyahu, Campbell, Aimee, Greiner, Miranda, Scodes, Jennifer, Meyers-Ohki, Sarah, Novo, Patricia, Nunes, Edward, Rotrosen, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838184/ https://www.ncbi.nlm.nih.gov/pubmed/36644220 http://dx.doi.org/10.1016/j.dadr.2022.100100 |
Ejemplares similares
-
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 “optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)”
por: Shulman, Matisyahu, et al.
Publicado: (2021) -
Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study
por: Karnik, Niranjan S., et al.
Publicado: (2021) -
The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study
por: Karnik, Niranjan S., et al.
Publicado: (2022) -
Cardiovascular variability, sociodemographics, and biomarkers of disease: the MIDUS study
por: Gruenewald, Tara, et al.
Publicado: (2023) -
Gender disparities in opioid treatment progress in methadone versus counseling
por: Guerrero, Erick, et al.
Publicado: (2021)